Tag: viral gastroenteritis market analysis

  • What’s Driving Growth in the Viral Gastroenteritis Market? Insights into Key Trends and Opportunities

    What’s Driving Growth in the Viral Gastroenteritis Market? Insights into Key Trends and Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Anticipated CAGR of the Viral Gastroenteritis Market, and What Factors Will Drive It?

    The viral gastroenteritis market has grown steadily in recent years. It is expected to increase from $6.75 billion in 2024 to $7.08 billion in 2025, with a CAGR of 5.0%. Historical market expansion has been driven by the prevalence of viral infections, global hygiene practices, advancements in diagnostics, increased global travel and tourism, and environmental and climate-related factors.

    The viral gastroenteritis market is expected to grow steadily, reaching $8.73 billion by 2029 at a CAGR of 5.4%. Growth in this sector will be supported by global health preparedness initiatives, the impact of climate change, the One Health approach, improved epidemiological surveillance systems, and enhanced education and public awareness campaigns. Major market trends include advancements in vaccine development, improvements in diagnostic technologies, the incorporation of telemedicine in disease diagnosis, increased collaborative research initiatives, personalized medicine approaches, and the expansion of digital health solutions.

    Which Macro and Microeconomic Factors Are Accelerating the Growth of the Market?

    The rise in gastrointestinal disorders is expected to foster the growth of the viral gastroenteritis market. Gastrointestinal disorders affect the digestive tract and viral gastroenteritis drugs and diagnostic treatments assist patients with appropriate care. For instance, a 2023 report from the IBD Clinical and Research Centre indicated that the prevalence of inflammatory bowel disease (IBD) in Canada was 825 per 100,000, with 320,000 cases in 2023. This is expected to increase by 2.44% annually, with projections showing 470,000 Canadians living with IBD by 2035. Thus, the growing prevalence of gastrointestinal disorders is contributing to the expansion of the viral gastroenteritis market.

    Request Your Free Viral Gastroenteritis Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

    Who Are the Top Companies Contributing to the Growth of the Viral Gastroenteritis Market?

    Major companies operating in the viral gastroenteritis market include:

    • Pfizer Inc.

    • Abbvie Inc.

    • Sanofi S.A.

    • Abbott Laboratories

    • GlaxoSmithKline Plc.

    How Are Technological Trends Affecting the Growth and Development of the Viral Gastroenteritis Market?

    Product innovation is a growing trend in the viral gastroenteritis market, with major players focused on developing new solutions to enhance their market position. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, received FDA approval for a liquid formulation of ROTARIX, an oral-dosing applicator-only vaccine for preventing rotavirus gastroenteritis in infants. This new ready-to-use format eliminates the need for vaccine reconstitution, providing healthcare providers with a more convenient and efficient solution. International clinical trials confirmed its safety, tolerability, and immunogenicity, reinforcing its market advantage over lyophilized formulations.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

    Which Key Segments Stand Out in Understanding the Composition of the Viral Gastroenteritis Market?

    The viral gastroenteritis market covered in this report is segmented –

    1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

    2) By Diagnosis: Physical Examination, Rapid Stool Test

    3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

    4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

    5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

    Subsegments:

    1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

    2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

    3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

    4) By Antimotility Agents: Loperamide, Diphenoxylate

    5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

    What Are the Key Regions Powering Growth in the Viral Gastroenteritis Market?

    North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Defines the Scope of the Viral Gastroenteritis Market?

    Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

    Browse Through More Similar Reports By The Business Research Company:

    Forklift Truck Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/forklift-truck-global-market-report

    Smart And Mobile Supply Chain Solutions Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/smart-and-mobile-supply-chain-solutions-global-market-report

    Warehouse Execution System Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/warehouse-execution-system-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s Driving Growth in the Viral Gastroenteritis Market? Insights into Key Trends and Opportunities

    What’s Driving Growth in the Viral Gastroenteritis Market? Insights into Key Trends and Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Anticipated CAGR of the Viral Gastroenteritis Market, and What Factors Will Drive It?

    The viral gastroenteritis market has grown steadily in recent years. It is expected to increase from $6.75 billion in 2024 to $7.08 billion in 2025, with a CAGR of 5.0%. Historical market expansion has been driven by the prevalence of viral infections, global hygiene practices, advancements in diagnostics, increased global travel and tourism, and environmental and climate-related factors.

    The viral gastroenteritis market is expected to grow steadily, reaching $8.73 billion by 2029 at a CAGR of 5.4%. Growth in this sector will be supported by global health preparedness initiatives, the impact of climate change, the One Health approach, improved epidemiological surveillance systems, and enhanced education and public awareness campaigns. Major market trends include advancements in vaccine development, improvements in diagnostic technologies, the incorporation of telemedicine in disease diagnosis, increased collaborative research initiatives, personalized medicine approaches, and the expansion of digital health solutions.

    Which Macro and Microeconomic Factors Are Accelerating the Growth of the Market?

    The rise in gastrointestinal disorders is expected to foster the growth of the viral gastroenteritis market. Gastrointestinal disorders affect the digestive tract and viral gastroenteritis drugs and diagnostic treatments assist patients with appropriate care. For instance, a 2023 report from the IBD Clinical and Research Centre indicated that the prevalence of inflammatory bowel disease (IBD) in Canada was 825 per 100,000, with 320,000 cases in 2023. This is expected to increase by 2.44% annually, with projections showing 470,000 Canadians living with IBD by 2035. Thus, the growing prevalence of gastrointestinal disorders is contributing to the expansion of the viral gastroenteritis market.

    Request Your Free Viral Gastroenteritis Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

    Who Are the Top Companies Contributing to the Growth of the Viral Gastroenteritis Market?

    Major companies operating in the viral gastroenteritis market include:

    • Pfizer Inc._x000D_

    • Abbvie Inc._x000D_

    • Sanofi S.A._x000D_

    • Abbott Laboratories_x000D_

    • GlaxoSmithKline Plc._x000D_

    How Are Technological Trends Affecting the Growth and Development of the Viral Gastroenteritis Market?

    Product innovation is a growing trend in the viral gastroenteritis market, with major players focused on developing new solutions to enhance their market position. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, received FDA approval for a liquid formulation of ROTARIX, an oral-dosing applicator-only vaccine for preventing rotavirus gastroenteritis in infants. This new ready-to-use format eliminates the need for vaccine reconstitution, providing healthcare providers with a more convenient and efficient solution. International clinical trials confirmed its safety, tolerability, and immunogenicity, reinforcing its market advantage over lyophilized formulations.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

    Which Key Segments Stand Out in Understanding the Composition of the Viral Gastroenteritis Market?

    The viral gastroenteritis market covered in this report is segmented –

    1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

    2) By Diagnosis: Physical Examination, Rapid Stool Test

    3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

    4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

    5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

    Subsegments:

    1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

    2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

    3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

    4) By Antimotility Agents: Loperamide, Diphenoxylate

    5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

    What Are the Key Regions Powering Growth in the Viral Gastroenteritis Market?

    North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Defines the Scope of the Viral Gastroenteritis Market?

    Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

    Browse Through More Similar Reports By The Business Research Company:

    Forklift Truck Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/forklift-truck-global-market-report

    Smart And Mobile Supply Chain Solutions Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/smart-and-mobile-supply-chain-solutions-global-market-report

    Warehouse Execution System Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/warehouse-execution-system-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s Driving Growth in the Viral Gastroenteritis Market? Insights into Key Trends and Opportunities

    What’s Driving Growth in the Viral Gastroenteritis Market? Insights into Key Trends and Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Anticipated CAGR of the Viral Gastroenteritis Market, and What Factors Will Drive It?

    The viral gastroenteritis market has grown steadily in recent years. It is expected to increase from $6.75 billion in 2024 to $7.08 billion in 2025, with a CAGR of 5.0%. Historical market expansion has been driven by the prevalence of viral infections, global hygiene practices, advancements in diagnostics, increased global travel and tourism, and environmental and climate-related factors.

    The viral gastroenteritis market is expected to grow steadily, reaching $8.73 billion by 2029 at a CAGR of 5.4%. Growth in this sector will be supported by global health preparedness initiatives, the impact of climate change, the One Health approach, improved epidemiological surveillance systems, and enhanced education and public awareness campaigns. Major market trends include advancements in vaccine development, improvements in diagnostic technologies, the incorporation of telemedicine in disease diagnosis, increased collaborative research initiatives, personalized medicine approaches, and the expansion of digital health solutions.

    Which Macro and Microeconomic Factors Are Accelerating the Growth of the Market?

    The rise in gastrointestinal disorders is expected to foster the growth of the viral gastroenteritis market. Gastrointestinal disorders affect the digestive tract and viral gastroenteritis drugs and diagnostic treatments assist patients with appropriate care. For instance, a 2023 report from the IBD Clinical and Research Centre indicated that the prevalence of inflammatory bowel disease (IBD) in Canada was 825 per 100,000, with 320,000 cases in 2023. This is expected to increase by 2.44% annually, with projections showing 470,000 Canadians living with IBD by 2035. Thus, the growing prevalence of gastrointestinal disorders is contributing to the expansion of the viral gastroenteritis market.

    Request Your Free Viral Gastroenteritis Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

    Who Are the Top Companies Contributing to the Growth of the Viral Gastroenteritis Market?

    Major companies operating in the viral gastroenteritis market include:

    • Pfizer Inc._x000D_

    • Abbvie Inc._x000D_

    • Sanofi S.A._x000D_

    • Abbott Laboratories_x000D_

    • GlaxoSmithKline Plc._x000D_

    How Are Technological Trends Affecting the Growth and Development of the Viral Gastroenteritis Market?

    Product innovation is a growing trend in the viral gastroenteritis market, with major players focused on developing new solutions to enhance their market position. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, received FDA approval for a liquid formulation of ROTARIX, an oral-dosing applicator-only vaccine for preventing rotavirus gastroenteritis in infants. This new ready-to-use format eliminates the need for vaccine reconstitution, providing healthcare providers with a more convenient and efficient solution. International clinical trials confirmed its safety, tolerability, and immunogenicity, reinforcing its market advantage over lyophilized formulations.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

    Which Key Segments Stand Out in Understanding the Composition of the Viral Gastroenteritis Market?

    The viral gastroenteritis market covered in this report is segmented –

    1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

    2) By Diagnosis: Physical Examination, Rapid Stool Test

    3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

    4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

    5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

    Subsegments:

    1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

    2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

    3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

    4) By Antimotility Agents: Loperamide, Diphenoxylate

    5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

    What Are the Key Regions Powering Growth in the Viral Gastroenteritis Market?

    North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Defines the Scope of the Viral Gastroenteritis Market?

    Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

    Browse Through More Similar Reports By The Business Research Company:

    Forklift Truck Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/forklift-truck-global-market-report

    Smart And Mobile Supply Chain Solutions Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/smart-and-mobile-supply-chain-solutions-global-market-report

    Warehouse Execution System Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/warehouse-execution-system-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s Driving Growth in the Viral Gastroenteritis Market? Insights into Key Trends and Opportunities

    What’s Driving Growth in the Viral Gastroenteritis Market? Insights into Key Trends and Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Anticipated CAGR of the Viral Gastroenteritis Market, and What Factors Will Drive It?

    The viral gastroenteritis market has grown steadily in recent years. It is expected to increase from $6.75 billion in 2024 to $7.08 billion in 2025, with a CAGR of 5.0%. Historical market expansion has been driven by the prevalence of viral infections, global hygiene practices, advancements in diagnostics, increased global travel and tourism, and environmental and climate-related factors.

    The viral gastroenteritis market is expected to grow steadily, reaching $8.73 billion by 2029 at a CAGR of 5.4%. Growth in this sector will be supported by global health preparedness initiatives, the impact of climate change, the One Health approach, improved epidemiological surveillance systems, and enhanced education and public awareness campaigns. Major market trends include advancements in vaccine development, improvements in diagnostic technologies, the incorporation of telemedicine in disease diagnosis, increased collaborative research initiatives, personalized medicine approaches, and the expansion of digital health solutions.

    Which Macro and Microeconomic Factors Are Accelerating the Growth of the Market?

    The rise in gastrointestinal disorders is expected to foster the growth of the viral gastroenteritis market. Gastrointestinal disorders affect the digestive tract and viral gastroenteritis drugs and diagnostic treatments assist patients with appropriate care. For instance, a 2023 report from the IBD Clinical and Research Centre indicated that the prevalence of inflammatory bowel disease (IBD) in Canada was 825 per 100,000, with 320,000 cases in 2023. This is expected to increase by 2.44% annually, with projections showing 470,000 Canadians living with IBD by 2035. Thus, the growing prevalence of gastrointestinal disorders is contributing to the expansion of the viral gastroenteritis market.

    Request Your Free Viral Gastroenteritis Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

    Who Are the Top Companies Contributing to the Growth of the Viral Gastroenteritis Market?

    Major companies operating in the viral gastroenteritis market include:

    • Pfizer Inc._x000D_

    • Abbvie Inc._x000D_

    • Sanofi S.A._x000D_

    • Abbott Laboratories_x000D_

    • GlaxoSmithKline Plc._x000D_

    How Are Technological Trends Affecting the Growth and Development of the Viral Gastroenteritis Market?

    Product innovation is a growing trend in the viral gastroenteritis market, with major players focused on developing new solutions to enhance their market position. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, received FDA approval for a liquid formulation of ROTARIX, an oral-dosing applicator-only vaccine for preventing rotavirus gastroenteritis in infants. This new ready-to-use format eliminates the need for vaccine reconstitution, providing healthcare providers with a more convenient and efficient solution. International clinical trials confirmed its safety, tolerability, and immunogenicity, reinforcing its market advantage over lyophilized formulations.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

    Which Key Segments Stand Out in Understanding the Composition of the Viral Gastroenteritis Market?

    The viral gastroenteritis market covered in this report is segmented –

    1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

    2) By Diagnosis: Physical Examination, Rapid Stool Test

    3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

    4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

    5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

    Subsegments:

    1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

    2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

    3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

    4) By Antimotility Agents: Loperamide, Diphenoxylate

    5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

    What Are the Key Regions Powering Growth in the Viral Gastroenteritis Market?

    North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Defines the Scope of the Viral Gastroenteritis Market?

    Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

    Browse Through More Similar Reports By The Business Research Company:

    Forklift Truck Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/forklift-truck-global-market-report

    Smart And Mobile Supply Chain Solutions Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/smart-and-mobile-supply-chain-solutions-global-market-report

    Warehouse Execution System Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/warehouse-execution-system-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 2024 Viral Gastroenteritis Market Outlook: Size, Share, and Key Growth Drivers

    2024 Viral Gastroenteritis Market Outlook: Size, Share, and Key Growth Drivers

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate is the Viral Gastroenteritis Market Anticipated to Experience from 2024-2033?

    In recent times, we have witnessed a substantial growth in the market size of viral gastroenteritis. The expansion will progress from a valuation of $6.34 billion in 2023 to $6.7 billion in 2024, indicating a compound annual growth rate (CAGR) of 5.7%. Factors such as the pervasiveness of viral infections, worldwide hygiene protocols, advancements in diagnostic procedures, global travel and tourism, and climate and environment-related factors contributed to the growth during the historic period.

    In the coming years, the market size for viral gastroenteritis is anticipated to experience consistent growth, reaching $8.1 billion by 2028, with a compound annual growth rate (CAGR) of 4.9%. Factors driving growth in the forecast period include global health readiness, effects of climate change, a unified health approach, epidemiological monitoring systems, as well as education and increased public awareness. Key trends anticipated during the forecast period encompass the development of vaccines, advancements in diagnostics, the use of telemedicine for diagnosis, joint research efforts, personalized treatment strategies, and the implementation of digital health solutions.

    Claim Your Free Sample of the Global Viral Gastroenteritis Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

    What Are the Significant Influencers of Growth in the viral gastroenteritis Market?

    The rise in occurrences of gastrointestinal conditions is predicted to fuel the expansion of the viral gastroenteritis market in the future. Diseases that manifest in or on any segment of the gastrointestinal tract are referred to as gastrointestinal (GI) disorders. Medications and diagnostic treatments for viral gastroenteritis benefit those affected by providing suitable and effective treatment. For example, a survey conducted in October 2021 by Bodibio, an American fitness and wellness firm, spanning 33 nations and involving 73,076 adults, pointed out that 40% of the participants suffered from a functional gastrointestinal disorder. This included all different forms of functional dyspepsia, irritable bowel syndrome, functional constipation, among others. Consequently, the rising incidence of gastrointestinal conditions is propelling the viral gastroenteritis market’s growth.

    What Key Segments Define the Viral Gastroenteritis Market?

    1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

    2) By Diagnosis: Physical Examination, Rapid Stool Test

    3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

    4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

    5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

    What Are the Key Developments Shaping the Viral Gastroenteritis Market?

    The viral gastroenteritis market is witnessing a growing trend of product innovation. To solidify their market standing, the leading companies are focusing on launching new products. For example, in November 2022, GlaxoSmithKline plc, a biopharmaceutical company based in the UK, was granted approval by the US Food and Drug Administration (FDA) for its ROTARIX oral-dosing applicator-only presentation (liquid formulation). This is designed to prevent rotavirus gastroenteritis in infants. The formulation means healthcare providers no longer need to reconstitute the vaccine dose when they use it. This approval is based on international clinical trials that showed the safety and tolerability of the formulation compared to the lyophilized version, and that it was not less potent in terms of immunogenicity.

    Order Now for Fast Delivery of Your Viral Gastroenteritis Market Report!

    https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

    What Regions Are Driving Expansion in the Viral Gastroenteritis Market?

    North America was the largest region in the viral gastroenteritis market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Viral Gastroenteritis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the viral gastroenteritis market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Viral Gastroenteritis Market Include

    1. Viral Gastroenteritis Market Executive Summary

    2. Viral Gastroenteritis Market Segments

    3. Viral Gastroenteritis Market Size And Template Market Growth Rate

    4. Key Viral Gastroenteritis Market Trends

    5. Major Viral Gastroenteritis Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Viral Gastroenteritis Market

    26. Top Viral Gastroenteritis Companies

    27. Viral Gastroenteritis Market Opportunities And Strategies

    28. Viral Gastroenteritis Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

    https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

    Viral Vectors And Plasmid DNA Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

    Antivirals Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Overview Of The Viral Gastroenteritis Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Viral Gastroenteritis Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The viral gastroenteritis market has witnessed robust growth in recent years, with significant projections for the future. The market size surged from $6.34 billion in 2023 to $6.7 billion in 2024, marking a compelling compound annual growth rate (CAGR) of 5.7%. This expansion owes itself to several key factors:

    Factors Driving Historic Growth

    • Prevalence of Viral Infections: The widespread occurrence of viral infections has necessitated the development of effective treatments and diagnostics.
    • Advancements in Diagnostics: Technological innovations have enhanced the accuracy and efficiency of diagnostic procedures.
    • Global Travel and Tourism: Increased international travel has contributed to the dissemination of gastrointestinal ailments worldwide.
    • Hygiene Practices: Global hygiene initiatives have played a pivotal role in combating viral gastroenteritis.
    • Climate and Environmental Factors: Changing environmental conditions have influenced disease patterns, necessitating adaptive healthcare strategies.

    View More On The Viral Gastroenteritis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

    Charting the Course Ahead
    The forecast for the viral gastroenteritis market remains optimistic, with steady growth anticipated in the coming years. By 2028, the market is projected to reach $8.1 billion, demonstrating a CAGR of 4.9%. Key drivers of growth in the forecast period include:

    Factors Fueling Future Growth

    • Global Health Preparedness: Heightened awareness and preparedness efforts are expected to bolster market expansion.
    • Climate Change Impact: Environmental shifts will likely influence disease prevalence, necessitating proactive healthcare measures.
    • Epidemiological Surveillance Systems: Enhanced surveillance capabilities will enable prompt detection and response to outbreaks.
    • Education and Public Awareness: Increased awareness about gastrointestinal disorders will drive demand for effective treatments.
    • One Health Approach: A holistic approach to healthcare encompassing human, animal, and environmental health will shape disease management strategies.

    Emerging Trends and Innovations

    In the forecast period, the viral gastroenteritis market is poised to witness transformative trends and innovations, including:

    Key Trends

    • Vaccine Development: Advancements in vaccine research hold promise for disease prevention.
    • Advanced Diagnostics: Innovations in diagnostic technologies will facilitate early detection and treatment.
    • Telemedicine in Diagnosis: Remote healthcare services will improve access to diagnosis and treatment.
    • Collaborative Research Initiatives: Partnerships between academia, industry, and government will drive innovation and knowledge exchange.
    • Personalized Medicine Approaches: Tailored treatment strategies based on individual patient characteristics will optimize therapeutic outcomes.
    • Digital Health Solutions: Digital platforms and tools will streamline healthcare delivery and patient management.

    Rising Prevalence of Gastrointestinal Disorders to Drive Market Growth

    The escalating prevalence of gastrointestinal disorders, encompassing a spectrum of ailments affecting the digestive tract, is a primary driver of market growth. Notably, a survey conducted across 33 countries revealed a significant incidence of functional gastrointestinal disorders among adults. This burgeoning prevalence underscores the demand for effective viral gastroenteritis treatments and diagnostics.

    Product Innovations Transforming the Viral Gastroenteritis Market

    Product innovation emerges as a pivotal trend shaping the viral gastroenteritis market landscape. Major players are leveraging innovation to fortify their market presence. For instance:

    Innovative Developments

    • Oral-Dosing Applicator for ROTARIX: GlaxoSmithKline PLC’s approval for an oral-dosing applicator-only presentation of ROTARIX streamlines vaccine administration, enhancing convenience for healthcare providers.
    • Diagnostic Expansion Through Acquisition: Hologic Inc.’s acquisition of Diagenode broadens its diagnostic portfolio, enabling expanded diagnostic capabilities across infections, including gastroenteritis.

    Segmentation and Regional Insights

    The viral gastroenteritis market is segmented based on drugs, diagnosis, indication, type of virus, and end-users. Notably, North America led the market in 2023, with Asia Pacific poised for rapid growth in the forecast period.

    In Conclusion

    The viral gastroenteritis market presents a dynamic landscape characterized by growth opportunities driven by evolving healthcare needs, technological advancements, and shifting disease patterns. As stakeholders continue to innovate and collaborate, the market is poised for sustained expansion, ensuring enhanced treatment outcomes and patient care on a global scale.

    Request A Sample Of The Global Viral Gastroenteritis Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12127&type=smp